Stock & Company Details
Enliven Therapeutics Inc $ELVN
Price:
N/A
N/A
74M
$3.4B
52 Week High:
N/A
10 Day Average Volume:
N/A
-27.32
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
ELVN technical indicators
Latest Enliven Therapeutics Inc (ELVN) indicator readings as of 2026-11-19.
ELVN's 14-day RSI is 50.1, in neutral territory. ADX reads 22.8, sitting between trending and range-bound. MACD (12, 26, 9) is 0.67, above the zero line.
Overview
Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially best-in-class or first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases.
Finance Bot
Ask your questions
Start by typing a question below.